Ersi Voskaridou, Evangelos Terpos. Show Affiliations »
Abstract
Entities: Chemical Disease Species
Mesh: See more » Bone DensityBone RemodelingCarrier Proteins/metabolismCase-Control StudiesCholecalciferol/therapeutic useFemaleGlycoproteins/metabolismHumansMaleMembrane Glycoproteins/metabolismOsteoporosis/drug therapyOsteoporosis/etiologyOsteoporosis/metabolismOsteoprotegerinRANK LigandReceptor Activator of Nuclear Factor-kappa BReceptors, Cytoplasmic and Nuclear/metabolismReceptors, Tumor Necrosis FactorSolubilityThalassemia/complicationsThalassemia/drug therapyThalassemia/metabolism
Substances: See more » Carrier ProteinsGlycoproteinsMembrane GlycoproteinsOsteoprotegerinRANK LigandReceptor Activator of Nuclear Factor-kappa BReceptors, Cytoplasmic and NuclearReceptors, Tumor Necrosis FactorTNFRSF11A protein, humanTNFRSF11B protein, humanTNFSF11 protein, humanCholecalciferol
Year: 2005 PMID: 15777350 DOI: 10.1111/j.1600-0609.2004.00395.x
Source DB: PubMed Journal: Eur J Haematol ISSN: 0902-4441 Impact factor: 2.997